Open AccessLung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors
Author(s) -
Yang Dafu,
Li Dan,
Dai Zhaoxia,
Ma Yutong,
Ou Qiuxiang,
Wu Xue,
Cui Saiqiong
Publication year - 2021
Publication title -
cancer communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 53
ISSN - 2523-3548
DOI - 10.1002/cac2.12128
Subject(s) - crizotinib , anaplastic lymphoma kinase , ceritinib , lung cancer , medicine , alk inhibitor , ros1 , adenocarcinoma , alectinib , targeted therapy , oncology , cancer research , pathology , cancer , malignant pleural effusion